Rxcurve
HCPCS J2183 · per 100 MG

Inj meropenem (wg crit care)

Products billed under this code include Meropenem.

Payment limit per 100 MG, by effective quarter, 3Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2183

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Meropenem WG Critical Care, LLC 44567-0402-06 120 $160.68
Meropenem Mylan Institutional LLC 72078-0081-06 120 $160.68

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $1.339 −$0.069 100 MG Inj meropenem (wg crit care) v1, posted September 17, 2026
3Q26 $1.408 −$0.068 100 MG Inj meropenem (wg crit care) v1, posted September 15, 2026
2Q26 $1.476 −$0.096 100 MG Inj meropenem (wg crit care) v1, posted September 15, 2026
1Q26 $1.572 −$0.048 100 MG Inj meropenem (wg crit care) v1, posted September 15, 2026
4Q25 $1.62 −$0.004 100 MG Inj meropenem (wg crit care) v1, posted September 8, 2026
3Q25 $1.624 +$0.02 100 MG Inj meropenem (wg crit care) v1, posted March 10, 2026
2Q25 $1.604 −$0.05 100 MG Inj meropenem (wg crit care) v1, posted March 10, 2026
1Q25 $1.654 +$0.037 100 MG Inj meropenem (wg crit care) v1, posted December 19, 2025
4Q24 $1.617 +$0.016 100 MG Inj meropenem (wg crit care) v1, posted June 11, 2025
3Q24 $1.601 – 100 MG Inj meropenem (wg crit care) v1, posted June 11, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files